Cancer Research

Skin cancer mystery revealed in Yin and Yang protein

December 29, 2019
Researchers in the UC Berkeley lab of John Kuriyan, Chancellor's Professor at the University of California, Berkeley in the departments of Molecular and Cell Biology and Chemistry, have utilized powerful NSF funded supercomputers at the University of Texas Advanced Computing Center and the Pittsburgh Supercomputing Center to uncover the mechanism that activates cell mutations found in about 50 percent of melanomas.

Ziyang Zhang named a Pew-Stewart Scholar selected to advance cutting-edge cancer research

June 13, 2023

Ziyang Zhang

The Pew Charitable Trusts and the Alexander and Margaret Stewart Trust have announced the 2023 class of the Pew-Stewart Scholars Program for Cancer Research. Our congratulations goes to Assistant Professor of Chemistry and Chemical Biology, Ziyang Zhang who has been named one of five scholars this year....

Dan Nomura receives ASPIRE Award for cancer research

February 23, 2023

Dan Nomura

Dan Nomura in his lab. Photo by Elena Zhukova.

The Mark Foundation for Cancer Research has announced twelve outstanding research projects to receive its latest round of ASPIRE awards. Grantees from top academic institutions in Germany...

The future of biochemistry

January 12, 2018

ACS Biochemistry Issue CoverThe ACS January 2018 Special Biochemistry Issue has included College of Chemistry professors Ming Hammond, Evan Miller, and David Savage among the 44 early career scientists identified as representing the future of biochemistry. These scientists are noted by the publication for tackling problems of biological relevance.

For more detailed information read the ACS...

Science world honors Kevan Shokat for high-impact cancer research

February 20, 2023

Kevan Shokat photographed at UCSF

Kevan Shokat photographed at UCSF. Photo by Noah Berger.

The UC San Francisco scientist who developed a successful approach to drugging a protein produced by the mutated KRAS gene has won two prestigious awards in the opening weeks of 2023. The discovery, made by...

An anti-cancer drug in short supply can now be made by microbes

September 1, 2022

Saccharomyces cerevisiae, also known as brewer’s yeast, has been dyed blue to be seen under a microscope.

Saccharomyces cerevisiae, also known as brewer’s yeast, is seen under a microscope. This species is used around the world to...

Vicinitas Therapeutics Launches to Advance Precision Medicines to Stabilize Key Proteins to Treat Disease

July 28, 2022

Logo for Vicinitas Therapeutics

Berkeley, CA

It was announced today that Vicinitas Therapeutics, a biotechnology company advancing a proprietary targeted protein stabilization platform to develop novel...

Novartis and UC Berkeley Extend Alliance to tackle undruggable diseases

July 28, 2022

Illustration of DUBTAC target

Illustration of DUBTAC in action against a target. (Courtesy Nomura Lab)

Novartis-Berkeley Translational Chemical Biology Institute combines Novartis expertise in chemical biology and medicinal chemistry with Berkeley’s expertise in covalent chemoproteomics and chemistry methodologies Research collaboration aims to unlock...

Scientists find trigger that sets off metastasis in pancreatic cancer

July 5, 2022

Illustration of Healthy pancreas (left) and metastatic tumors on the liver (right)

Scientists have found that cancers in the pancreas (left) readily metastasize because these tumors suppress levels of an enzyme, MSRA, that pulls oxygen atoms off amino acids called methionine. As MSRA levels decrease, methionines on...

An expert on 'undruggable' targets tackles the coronavirus

October 5, 2020

Dan Nomura

Nomura in his lab at UC Berkeley. Photo: Elena Zhukova

Throughout the grim reality of a global pandemic that has disrupted normal life for months, one persistent bright spot has been the robust response of the biomedical research community. The battle to develop vaccines and drugs to fight the SARS-CoV-2 virus and COVID-19, the disease which it causes,...